Literature DB >> 19082466

Long-term trends of the incidence of hepatocellular carcinoma in the Nagasaki prefecture, Japan.

Naota Taura1, Hiroshi Yatsuhashi, Kazuhiko Nakao, Tatsuki Ichikawa, Hiromi Ishibashi.   

Abstract

The incidence of hepatocellular carcinoma (HCC) in Japan is still increasing. The aim of the present study was to analyze the epidemiological trend of HCC in the Western area of Japan, Nagasaki. A total of 1,807 patients with HCC diagnosed at our two hospitals between 1981 and 2005 were consecutively recruited for this study. Cohorts of patients with HCC were categorized into five-year intervals. The etiology of HCC was categorized into four groups: HCC-B: HBsAg positive, HCVAb negative, HCC-C: HCVAb positive, HBsAg negative, HCC-BC: both of HBsAg and HCVAb positive and HCC-nonBC: both of HBsAg and HCVAb negative. The number and proportion of HCC-B cases decreased from 1986 to 1990 and thereafter stabilized, whereas those of HCC-C reached the peak from 1995 to 2000 and thereafter decreased. On the other hand, the number and ratio of the HCC-nonBC cases continued to increase in the whole period. The male/female ratio of HCC-C patients decreased from 6.4 in the period 1981-1985 to 1.9 in 2001-2005, indicating clearly the increase of female patients. On the other hand, the male/female ratio of other types of HCC patients did not change during the period. HCC patients rapidly increased from 1981 to 2000 and this increase was originated from that of HCC-C. The increase of the median age and the number of female patients with HCC-C was also demonstrated. The increase in the number and the proportion of the HCC-nonBC patients was also significant.

Entities:  

Mesh:

Year:  2009        PMID: 19082466

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

Review 1.  Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.

Authors:  Davide Roccarina; Avik Majumdar; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-10

2.  Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma.

Authors:  Naota Taura; Tatsuki Ichikawa; Hisamitsu Miyaaki; Hiroshi Yatsuhashi; Hiromi Ishibashi; Kazuhiko Nakao
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

Review 3.  Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.

Authors:  Avik Majumdar; Davide Roccarina; Douglas Thorburn; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-03-28

4.  Bioinformatics analysis of constructing a HCV-related hepatocellular carcinoma miRNA-mRNA regulation network.

Authors:  Rui Hao; He Lu; Yanan Guo; Qianqian Liu; Lu Wang; Yang Wang; Ailong Huang; Zeng Tu
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

5.  Factors associated with the overall survival of elderly patients with hepatocellular carcinoma.

Authors:  Hideki Fujii; Yoshito Itoh; Naoki Ohnishi; Masafumi Sakamoto; Tohru Ohkawara; Yoshihiko Sawa; Koichi Nishida; Yasuo Ohkawara; Kanji Yamaguchi; Masahito Minami; Takeshi Okanoue
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

6.  Frequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinoma.

Authors:  Naota Taura; Tatsuki Ichikawa; Hisamitsu Miyaaki; Eisuke Ozawa; Takuya Tsutsumi; Shotaro Tsuruta; Yuji Kato; Takashi Goto; Noboru Kinoshita; Masanori Fukushima; Hiroyuki Kato; Kazuyuki Ohata; Kazuo Ohba; Junichi Masuda; Keisuke Hamasaki; Hiroshi Yatsuhashi; Kazuhiko Nakao
Journal:  Med Sci Monit       Date:  2013-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.